Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription 31.08.2026 3 Ann Surg Oncol 4 BMC Cancer 3 Clin Cancer Res 1 Clin Med Insights Oncol 1 Eur J Cancer 2 Eur J Gastroenterol Hepatol 1 Eur J Surg Oncol 1 Gut 1 Int J Colorectal Dis 3 J Clin Oncol 2 J Natl Cancer Inst 2 Lancet Oncol 1 Nat Rev Cancer 1 Oncogene 1 Oncology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. CHEN YC, Chang SC, Tsai YY, Ke TW, et al
   ASO Visual Abstract: Prophylactic Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Colorectal Cancer: Systematic Review and Meta-Analysis.
   Ann Surg Oncol. 2026 Aug 22. doi: 10.1245/s10434-026-20463.
   PubMed        
   
   
2. WROBEL D, Rogaczewski P, Dabrowski P, Olejek W, et al
   Complete Resection of Simultaneous Hepatic and Pulmonary Metastases from Colorectal Cancer in the Era of Modern Systemic and Surgical Therapies: A Systematic Review and Meta-Analysis.
   Ann Surg Oncol. 2026 Aug 22. doi: 10.1245/s10434-026-20323.
   PubMed         Abstract available
   
   
3. MORGAN RB, Marincola Smith P
   ASO Author Reflections: Should Oophorectomy be Routine in Cytoreductive Surgery for Colorectal Cancer-Related Peritoneal Carcinomatosis?
   Ann Surg Oncol. 2026 Aug 22. doi: 10.1245/s10434-026-20442.
   PubMed        
   
   

   
   BMC Cancer

4. WU P, Zhou Q, Zhu H, Zhuang Y, et al
   Retraction Note: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
   BMC Cancer. 2026;26:1007.
   PubMed        
   
   
5. JANG JY, Lim H, Ko J, Lee JH, et al
   Evolution of treatment patterns and survival outcomes in non-metastatic rectal cancer: a 15-year real-world single-center analysis.
   BMC Cancer. 2026;26:1020.
   PubMed         Abstract available
   
   
6. YUE X, Kong Y, Huang X, Tang F, et al
   Impact of time to ablation on survival outcomes in patients with colorectal liver metastases: an inverse probability-weighted cohort study.
   BMC Cancer. 2026;26:1011.
   PubMed         Abstract available
   
   
7. ETESAMI M, Forouzesh F, Hooshmand A, Niasar MS, et al
   Investigating the expression of CTLA-4 and CD28 genes as immune regulators in patients with colorectal polyps.
   BMC Cancer. 2026;26:1016.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

8. SCHLECHTER BL, Fakih MG, Tsimberidou AM, Bullock AJ, et al
   Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.
   Clin Cancer Res. 2026 Aug 28. doi: 10.1158/1078-0432.CCR-26-1610.
   PubMed         Abstract available
   
   
9. SHAH MA, Hissong E, Jafari MD, Kasi PM, et al
   Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial.
   Clin Cancer Res. 2026 Aug 26. doi: 10.1158/1078-0432.CCR-26-0998.
   PubMed         Abstract available
   
   
10. XU T, Parseghian CM, Zhang Y, Chen Z, et al
    EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.
    Clin Cancer Res. 2026 Aug 24. doi: 10.1158/1078-0432.CCR-26-2128.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Oncol

11. LI W, Peng Y, Ye C, Lu Y, et al
    Impact of Preoperative Anemia on Short-Term Outcomes After Colorectal Cancer Surgery: How the Choice of Diagnostic Criteria Leads to Conflicting Findings.
    Clin Med Insights Oncol. 2026;20:11795549261476196.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

12. BENHIMA N, Audisio A, Gallio C, Ricco G, et al
    Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.
    Eur J Cancer. 2026;245:116911.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

13. KUMAR R, Mudassar Z, Luqman S, Qadir S, et al
    Clinical insights on utility of colon capsule endoscopy in colorectal cancer and postpolypectomy surveillance.
    Eur J Gastroenterol Hepatol. 2026;38:1236.
    PubMed        
    
    
14. LEE JY, Noh HY, Baek YH, Noh MH, et al
    Endoscopic mucosal resection with precutting vs. anchoring technique using snare tip for 10-25 mm nonpedunculated colorectal polyps: a randomized controlled trial.
    Eur J Gastroenterol Hepatol. 2026;38:1180-1186.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

15. YAN Z, Yu F, Chen C, Huang Y, et al
    Procedure-specific prediction of surgical difficulty in laparoscopic and robotic right hemicolectomy: Interpretable machine learning models.
    Eur J Surg Oncol. 2026;52:111997.
    PubMed         Abstract available
    
    

    
    Gut

16. SHIRAI N, Bhosle A, Nzabarushimana E, Shen J, et al
    Multi-kingdom signatures of the gut microbiome in Lynch syndrome: a prospective model for colorectal cancer evolution.
    Gut. 2026 Aug 25:gutjnl-2026-339088. doi: 10.1136/gutjnl-2026-339088.
    PubMed        
    
    

    
    Int J Colorectal Dis

17. HERNANDEZ-YAGUE X, Lopez-Ben S, Aula-Olivar A, Carbajal-Ochoa W, et al
    Sinusoidal injury and portal hypertension after hepatectomy for colorectal liver metastases: predictors, risk stratification, and clinical outcomes.
    Int J Colorectal Dis. 2026;41:141.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

18. SUNAKAWA Y, Shiozawa M, Watanabe T, Ota H, et al
    Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
    J Clin Oncol. 2026 Aug 27:JCO2600355. doi: 10.1200/JCO-26-00355.
    PubMed         Abstract available
    
    
19. TANG Y, Zhou HT, Xu TZ, Li N, et al
    Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.
    J Clin Oncol. 2026;44:2371-2378.
    PubMed         Abstract available
    
    
20. WANG X, Tang Y, Lu J, Meng W, et al
    Total Neoadjuvant Therapy With Long-Course Radiotherapy Versus Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer (TNTCRT): A Multicenter, Randomized, Phase III Trial.
    J Clin Oncol. 2026;44:2409-2421.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

21. YIN J, Francis KE, Lopes GS, So J, et al
    Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.
    J Natl Cancer Inst. 2026 Aug 24:djag287. doi: 10.1093.
    PubMed         Abstract available
    
    
22. RAEISI M, Andre T, Shi Q, Yoshino T, et al
    Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.
    J Natl Cancer Inst. 2026 Aug 22:djag291. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

23. BACH SP, Sebag-Montefiore D, Homer V, Gilbert A, et al
    Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phas
    Lancet Oncol. 2026;27:1120-1132.
    PubMed         Abstract available
    
    
24. SONG Z, Zhu L, Liu Y, Lin R, et al
    Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRAS(G12C) mutation: a multicentre, randomised, phase 1b/2 trial.
    Lancet Oncol. 2026;27:1133-1145.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

25. TIAN R, Azadnajafabad S, Waters EA, Balskus EP, et al
    Shaping the future of early-onset colorectal cancer prevention.
    Nat Rev Cancer. 2026 Aug 26. doi: 10.1038/s41568-026-00965.
    PubMed         Abstract available
    
    

    
    Oncogene

26. ERKAN EP, Hamalainen E, Kolikova J, Nikupaavola T, et al
    Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1.
    Oncogene. 2026 Aug 21. doi: 10.1038/s41388-026-03957.
    PubMed         Abstract available
    
    

    
    Oncology

27. HU K, Hu X, Jiang T, Dai X, et al
    Hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery and systemic therapy improves prognosis in colorectal cancer with peritoneal metastases: an updated meta-analysis.
    Oncology. 2026 Aug 24:1. doi: 10.1159.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

28. NEMATI H, Suijkerbuijk SJE, de Graaf J
    Cell competition driven by secreted ligands: Modeling liver metastasis of colorectal cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2531078123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum